Page last updated: 2024-09-03

saclofen and reserpine

saclofen has been researched along with reserpine in 1 studies

Compound Research Comparison

Studies
(saclofen)
Trials
(saclofen)
Recent Studies (post-2010)
(saclofen)
Studies
(reserpine)
Trials
(reserpine)
Recent Studies (post-2010) (reserpine)
10702015,546223436

Protein Interaction Comparison

ProteinTaxonomysaclofen (IC50)reserpine (IC50)
Bile salt export pumpHomo sapiens (human)8.7875
ATP-dependent translocase ABCB1Homo sapiens (human)3.2092
Quinolone resistance protein NorAStaphylococcus aureus8.5429
Mu-type opioid receptorHomo sapiens (human)4.152
Chromaffin granule amine transporterHomo sapiens (human)0.05
Synaptic vesicular amine transporterRattus norvegicus (Norway rat)0.0034
Synaptic vesicular amine transporterHomo sapiens (human)0.0147

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aceves, J; Erlij, D; Florán, B; Nava-Asbell, C; Paz-Bermudez, F1

Other Studies

1 other study(ies) available for saclofen and reserpine

ArticleYear
GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Neuropharmacology, 2007, Volume: 53, Issue:5

    Topics: Animals; Baclofen; Benzazepines; Cyclic AMP-Dependent Protein Kinases; Data Interpretation, Statistical; Dopamine Antagonists; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, GABA-B; Reserpine; Substantia Nigra

2007